Enhanced therapeutic effects of umbilical cord mesenchymal stem cells after prolonged treatment for HBV-related liver failure and liver cirrhosis.

Yifan JiaXin ShuXiaoan YangHaixia SunHuijuan CaoHong CaoKa ZhangQihuan XuGang LiYang Yang

Published in: Stem cell research & therapy (2020)

Peripheral infusion of UCMSCs showed good therapeutic effects for HBV-related liver failure and liver cirrhosis. Prolonging the treatment course can increase the curative effect of UCMSCs for end-stage liver disease, especially for patients with cirrhosis.

Keyphrases

liver failure
hepatitis b virus
mesenchymal stem cells
umbilical cord
bone marrow
low dose
prognostic factors